evans blue has been researched along with Acute Necrotizing Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahám, CS; Deli, MA; Farkas, G; Mándi, Y; Márton, J; Nagy, Z; Takács, T | 1 |
| Antoniu, BA; Balcom, JH; Fernández-del Castillo, CF; Keck, T; Lewandrowski, K; Warshaw, AL | 1 |
2 other study(ies) available for evans blue and Acute Necrotizing Pancreatitis
| Article | Year |
|---|---|
Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6.
Topics: Amylases; Animals; Blood-Brain Barrier; Brain; Brain Edema; Cholagogues and Choleretics; Disease Models, Animal; Encephalitis; Evans Blue; Fluorescein; Interleukin-6; Male; Organ Size; Pancreas; Pancreatitis, Acute Necrotizing; Rats; Rats, Wistar; Taurocholic Acid; Tumor Necrosis Factor-alpha | 1998 |
Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis.
Topics: Animals; Benzamidines; Capillary Permeability; Complement Inactivator Proteins; Evans Blue; Gabexate; Guanidines; Injections, Intra-Arterial; Injections, Intravenous; Lung; Male; Oligopeptides; Pancreas; Pancreatitis, Acute Necrotizing; Peritoneum; Peroxidase; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Serine Proteinase Inhibitors; Survival Rate | 2001 |